Syndax Pharmaceuticals (SNDX) Notes Payables (2015 - 2021)
Syndax Pharmaceuticals (SNDX) posted quarterly Notes Payables of $187000.0 for Q4 2021, up 40.6% quarter-over-quarter from $133000.0 in Q4 2015.
Powered by 
Analysis
Syndax Pharmaceuticals (SNDX) Notes Payables (2015 - 2021) Analysis & Trends
Syndax Pharmaceuticals' Notes Payables history runs 2 years deep, the most recent figure standing at $187000.0 for Q4 2021.
- In Q4 2021, Notes Payables changed N/A year-over-year to $187000.0; the TTM figure through Dec 2021 stood at $187000.0 (changed N/A YoY), while the FY2021 annual figure was $187000.0, changed N/A from the prior year.
- Notes Payables for Q4 2021 stood at $187000.0, up from $133000.0 in the prior quarter.
- The five-year high for Notes Payables was $187000.0 in Q4 2021, with the low at $187000.0 in Q4 2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Syndax Pharmaceuticals | 1.83 Bn | 1.28 Bn | 60.67 Mn |